Patent ID: 11918559
Assignee: PRIMUS PHARMACEUTICALS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 12:
13. The tablet of claim 12, wherein the tablet consists essentially of:
a) 640 mg micronized and non-micronized metaxalone,
b) 10-30 weight parts propylene glycol alginate,
c) 10-30 weight parts alginic acid, and,
d) 4-6 weight parts magnesium stearate,
e) wherein said metaxalone consists essentially of 40-80 wt % micronized metaxalone and 20-60 wt % non-micronized metaxalone,
f) wherein 90% of said micronized metaxalone are in the range of 50-500 microns, and,
g) wherein 2-10% of said non-micronized metaxalone are retained on a #30 sieve and 25-45% of said non-micronized metaxalone are retained on a #120 sieve.